Ophthalmic Drugs Market Report 2026

Ophthalmic Drugs Market Overview

• Ophthalmic Drugs market size has reached to $42.25 billion in 2025 • Expected to grow to $61.21 billion in 2030 at a compound annual growth rate (CAGR) of 7.9% • Growth Driver: Rising Ophthalmic Disorders Fueling Growth In Ophthalmic Drug Market • Market Trend: Preservative-Free Drug To Provide An Effective Treatment Option • North America was the largest region in 2025.

What Is Covered Under Ophthalmic Drugs Market?

Ophthalmic drugs refer to a class of pharmaceutical drugs or medicines used for treating diseases that affect the eye or vision. This medication is used to treat eye infections The main types of ophthalmic drugs are prescription drugs and over-the-counter drugs. Prescription ophthalmic drugs refer to types of drugs that can be obtained only using a licensed doctor's or medical practitioner's prescription. The various class includes anti-allergy, anti-inflammatory, anti-glaucoma, and other class for diseases like dry eye, eye allergy, glaucoma, eye infection, retinal disorders, uveitis, and other diseases. The various dosage forms include liquid ophthalmic drug forms, solid ophthalmic drug forms, semisolid ophthalmic drug forms, and multicompartment drug delivery systems. These are distributed through various distribution channels, such as hospital pharmacies, drug stores, and online pharmacies.

What Is The Ophthalmic Drugs Market Growth Forecast?

The ophthalmic drugs market size is expected to see strong growth in the next few years. It will grow to $61.21 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to advancement in sustained-release ocular drug delivery, increasing awareness of eye health, growth in retinal disorder treatments, rising healthcare expenditure in emerging economies, expanding otc ophthalmic product adoption. Major trends in the forecast period include rising prevalence of chronic eye disorders, growing demand for dry eye therapies, increased adoption of combination ophthalmic drugs, shift toward preservative-free formulations, expansion of online pharmacies for eye medications.

Global Ophthalmic Drugs Market Segmentation

1) By Type: Prescription Drugs, Over-The-Counter Drugs 2) By Class: Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes 3) By Disease: Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, Other Diseases 4) By Dosage Form: Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems 5) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies Subsegments: 1) By Prescription Drugs: Antiglaucoma Agents, Anti-inflammatory Drugs, Antibiotics, Antivirals, Corticosteroids, Other Prescription Drugs 2) By Over-The-Counter Drugs: Artificial Tears, Allergy Relief Medications, Redness Relievers, Ocular Vitamins And Supplements, Other OTC Drugs

What Is The Driver Of The Ophthalmic Drugs Market?

The increase in the prevalence of ophthalmic disorders is expected to propel the growth of the ophthalmic drug market going forward. Ophthalmic disorders refer to a disorder or disease that affects the eye and other parts of the eye, causing impairment of vision and other eye ailments. Ophthalmic drugs are pharmaceutical drugs or medicines used for treating diseases that affect the eye or vision, as a result, the increase in the prevalence of ophthalmic disorders increases the demand for the ophthalmic drug market. For instance, in August 2023, according to the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, at least 2.2 billion people worldwide were living with near or distance vision impairment in 2023 over 1 billion of which were preventable or untreated with refractive errors and cataracts as the primary causes, limited intervention reach at just 36% and 17%, respectively. The increase in the prevalence of ophthalmic disorders is driving the ophthalmic drug industry.

Key Players In The Global Ophthalmic Drugs Market

Major companies operating in the ophthalmic drugs market are AbbVie Inc., Alcon Inc., Bausch & Lomb Incorporated, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Nicox S.A., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Viatris Inc., Akorn Incorporated, GlaxoSmithKline plc, Bayer AG, Senju Pharmaceutical Co. Ltd., Aerie Pharmaceuticals Inc., Kala Pharmaceuticals Inc., Aurobindo Pharma Ltd., Eyevance Pharmaceuticals, Acucela Inc., Dompe Farmaceutici S.p.A., Laboratoires Théa

Global Ophthalmic Drugs Market Trends and Insights

Major companies operating in the ophthalmic drugs market are focused on developing preservative-free drugs such as preservative-free latanoprost to provide an effective treatment option. Preservative-free latanoprost refers to a formulation of the medication latanoprost, which is used to treat conditions such as glaucoma. For instance, in September 2023, Thea Pharma, a US-based pharmaceutical company specializing in the commercialization of eye care products, launched Iyuzeh (latanoprost ophthalmic solution) 0.005%, the first preservative-free latanoprost for primary open-angle glaucoma (POAG) and ocular hypertension (OHT) in the US. Iyuzeh, approved by the FDA in December 2022, provides an effective treatment option for over 60 million people globally affected by glaucoma.

What Are Latest Mergers And Acquisitions In The Ophthalmic Drugs Market?

In November 2025, Harrow Inc., a U.S.-based provider of ophthalmic disease management solutions, acquired Melt Pharmaceuticals for an undisclosed amount. With this acquisition, Harrow aims to expand its ophthalmic drug portfolio and strengthen its position in procedural sedation by integrating Melt’s non-opioid, non-intravenous sublingual sedation therapies into its broader ophthalmic and outpatient care offerings. Melt Pharmaceuticals is a U.S.-based clinical-stage company developing non-opioid, non-IV oral dissolving tablet sedation therapies for medical procedures across ophthalmology and other outpatient settings.

Regional Insights

North America was the largest region in the ophthalmic drugs market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Ophthalmic Drugs Market?

The ophthalmic drugs market consists of ophthalmic sales of anti-angiogenic drugs, anti-vascular endothelial growth factor drugs, anti-uveitis drugs, and prostaglandin analogs. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Ophthalmic Drugs Market Report 2026?

The ophthalmic drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.